Purchases and Sales Made in Q4 2024 in Protalix Bio Therapeutics, Inc. (PLX)
This table provides information about the institutional ownership of Protalix Bio Therapeutics, Inc. (PLX) during Q4 2024. The information is specifically focused on institutions that hold shares of Protalix BioTherapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 11, 2025
Q4 2024
|
Prudential Financial Inc
Newark, NJ |
BUY
|
- |
36.4KNew |
$36K - $69.9K
|
36.4K
$91.7K
|
|
|
Jan 22, 2025
Q4 2024
|
Pfg Investments, LLC
Woodbury, NY |
BUY
|
- |
20.7KNew |
$20.5K - $39.8K
|
20.7K
$52.2K
|
|
|
Feb 04, 2025
Q4 2024
|
Y Intercept (Hong Kong) LTD
|
BUY
|
- |
18.8KNew |
$18.6K - $36.1K
|
18.8K
$47.4K
|
|
|
Feb 12, 2025
Q4 2024
|
Citigroup Inc
|
BUY
|
- |
632New |
$626 - $1.21K
|
632
$1.59K
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-531- 1.06% |
$526 - $1.02K
|
49.7K
$125K
|
|
|
Feb 10, 2025
Q4 2024
|
Kestra Advisory Services, LLC
|
SELL
|
- |
-2K- 12.5% |
$1.98K - $3.84K
|
14K
$35.3K
|
|
|
Feb 11, 2025
Q4 2024
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-9.11K- 21.0% |
$9.02K - $17.5K
|
34.3K
$86.4K
|
|
|
Feb 07, 2025
Q4 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-129K- 29.75% |
$128K - $249K
|
306K
$770K
|